1 / 9

Live, attenuated intranasal H1N1 vaccine

Live, attenuated intranasal H1N1 vaccine. Indications. Healthy people 2-24 years old Those 25-49 and Live with or care for infants younger than 6 months Health care or emergency medical personnel As becomes more available, any healthy 2-49 year old. Contraindications. Allergy to:

philena-demetria
Download Presentation

Live, attenuated intranasal H1N1 vaccine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Live, attenuated intranasal H1N1 vaccine

  2. Indications • Healthy people 2-24 years old • Those 25-49 and • Live with or care for infants younger than 6 months • Health care or emergency medical personnel • As becomes more available, any healthy 2-49 year old

  3. Contraindications • Allergy to: • Previous influenza vaccine • Eggs, egg products, gentamicin, gelatin, arginine • Fever or acute illness • Age less than 2 or greater than 49 • Pregnant females • Immunocompromised or contact with • History Guillain-Barre syndrome • Long term medical condition

  4. Contraindications • All not absolute • Discuss with nurse or physician • May “qualify” for injection

  5. Vaccine Considerations • For 2009, only one manufacturer • MedImmune • Supplied in pre-filled unit-dose nasal syringes • Storage: 35-46° F (2-8° C) • Can be administered at same time as any other vaccine EXCEPT another intra-nasal vaccine

  6. Dosing • 0.2mL (0.1mL per nostril) • Dosing same regardless of age • Age 2-9: 2 doses 3-4 weeks apart • Age 10-49: 1 dose sufficient

  7. Procedure • Obtain and verify vaccine • Colorless to pale yellow • Clear to slightly cloudy • Some small proteinaceous particles may be present • Ensure VAR complete

  8. Procedure • Patient in upright position • Remove rubber tip protector • Insert tip just inside nare • Rapidly depress plunger until dose-divider clip stops • Remove from nose, remove dose-divider clip, and administer remainder in opposite nare

  9. Considerations • If patient sneezes, no need to repeat • Immunocompromised should not give vaccine • Possible reactions • Runny nose or congestion • Fever, chills, malaise, myalgia • Headache, sore throat, nausea, vomiting

More Related